List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 281 studies with search of: Aldesleukin OR Proleukin[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
2 Completed A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
Conditions: Cytomegalovirus Retinitis;   HIV Infections
Intervention: Drug: Aldesleukin
3 Active, not recruiting Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People
Condition: HIV Infections
Intervention: Drug: Aldesleukin
4 Completed An International Study to Evaluate Anti-HIV Therapy Plus Interleukin-2 (rIL-2) in HIV Positive Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
5 Active, not recruiting Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
6 Completed A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3
Condition: HIV Infections
Intervention: Drug: Aldesleukin
7 Completed A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine;   Drug: Didanosine;   Drug: Aldesleukin
8 Recruiting Interleukin 2, Aldesleukin and Entinostat for Kidney Cancer
Condition: Renal Cell Carcinoma
Intervention: Drug: Aldesleukin
9 Recruiting Aldesleukin in Patients With Metastatic Renal Cell Carcinoma and Metastatic Melanoma
Conditions: Metastatic Renal Cell Carcinoma;   Metastatic Melanoma
Intervention: Drug: Aldesleukin
10 Not yet recruiting A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Efavirenz;   Drug: Stavudine;   Drug: Didanosine;   Drug: Aldesleukin
11 Active, not recruiting Interleukin-2 With and Without Antiretroviral Therapy to Treat HIV-1 Infection
Conditions: HIV Infections;   HIV
Intervention: Drug: Interleukin-2, Proleukin
12 Completed Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection
Condition: HIV Infections
Interventions: Drug: Interleukin-2 SA;   Drug: HAART
13 Recruiting Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
Condition: Metastatic Melanoma
Intervention: Drug: Proleukin and Dacarbazine
14 Completed The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Condition: HIV Infections
Intervention: Drug: Aldesleukin
15 Active, not recruiting Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Condition: HIV Infections
Interventions: Drug: Aldesleukin;   Drug: ART
16 Completed A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Condition: HIV Infections
Intervention: Drug: Aldesleukin
17 Recruiting Laboratory-Treated Autologous Peripheral Blood Lymphocytes, Aldesleukin, Cyclophosphamide, and Fludarabine in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Intervention: Biological: aldesleukin
18 Completed Chemotherapy Followed By Autologous Natural Killer Cells and Aldesleukin in Treating Patients With Metastatic Melanoma or Kidney Cancer
Conditions: Kidney Cancer;   Melanoma (Skin)
Interventions: Biological: aldesleukin;   Biological: therapeutic autologous lymphocytes;   Drug: cyclophosphamide;   Drug: fludarabine phosphate
19 Completed Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load
Condition: HIV Infections
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Drug: Aldesleukin
20 Completed Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination
Condition: HIV Infections
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Drug: Aldesleukin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services